Evaluation of Adjunctive Injectable PRF Therapy Used in Conjunction With Scaling and Root Planning
Primary Purpose
Periodontal Pockets
Status
Completed
Phase
Not Applicable
Locations
Syrian Arab Republic
Study Type
Interventional
Intervention
: i-PRF
saline
Sponsored by
About this trial
This is an interventional treatment trial for Periodontal Pockets focused on measuring periodontal pockets, injectable platelet-rich fibrin, saline
Eligibility Criteria
Inclusion Criteria:
- Patients are in general good health.
- Patients are from both gender and are adult.
- A sign informed consent from participation and permission to use obtained data for research purposes.
- They have not taken medication known to interfere with periodontal tissue health or healing in the preceding 6 months.
- Presence of bilateral periodontal pockets (≥5 mm) on the minimum of 2 teeth in each side.
Exclusion Criteria:
- Patients less than 18 years' old
- Immunosuppressive systemic diseases (like cancer, AIDS, diabetes…)
- clotting and Hematological disorders
- Medications influence on the gingival and periodontal tissues (like calcium channel blockers, or Long-term steroid use
- The teeth with poor bad filling and poorly fitted restorations
Sites / Locations
- Syrian Private University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
i-PRF (Test)
saline (Control)
Arm Description
injected subgingivally i-PRF after scaling and root planing
injected subgingivally saline after scaling and root planing
Outcomes
Primary Outcome Measures
Clinical attachment level (CAL)
measure as the change in distance from the cementoenamel junction to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina")
Probing pocket depth (PD)
measure as the change in distance from the gingival margin GM to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina")
Secondary Outcome Measures
full mouth Plaque Index Quigely Hein Index (modified by Turesky et al, 1970)
0 No plaque
Separate flecks of plaque at the cervical margin of the tooth
A thin continuos band of plaque (up to one mm) at the cervical margin of the tooth
A band of plaque wider than one mm but covering less than one-third of the crown of the tooth
Plaque covering at least one-third but less than two-thirds of the crown of the tooth
Plaque covering two-thirds or more of the crown of the tooth labial/ buccal and lingual surfaces are assessed after using disclosing solution.
An index for the entire mouth is determined by dividing the total score by the number surfaces examined.
Modified Gingival Index (Trombelli et al. 2004)
0 = Normal gingiva;
= Mild inflammation - slight change in color and slight edema;
= Moderate inflammation - redness, edema and glazing;
= Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding.
will be evaluated visually
Bleeding on probing (BOP)
All six sites of all teeth are assessed with regard to whether probing elicits bleeding (+) or not (-). The severity of gingivitis is expressed as a percentage.
- no bleeding upon probing (not recorded)
+ bleeding upon probing
Calculation:
BOP= Number of bleeding sites x100/ Number of sites evaluated will be evaluated visually and used a UNC-15 mm "University of North Carolina" periodontal probe
Full Information
NCT ID
NCT03839849
First Posted
January 27, 2019
Last Updated
May 12, 2020
Sponsor
Syrian Private University
1. Study Identification
Unique Protocol Identification Number
NCT03839849
Brief Title
Evaluation of Adjunctive Injectable PRF Therapy Used in Conjunction With Scaling and Root Planning
Official Title
Clinical Effectiveness of a Topical Subgingival Application of Injectable Platelet-rich Fibrin as Adjunctive Therapy to Scaling and Root Planing. A Double-blind Split Mouth Randomized Prospective Comparative Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
February 9, 2019 (Actual)
Primary Completion Date
September 30, 2019 (Actual)
Study Completion Date
December 30, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Syrian Private University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Clinical evaluation of local administration of injectable PRF (injectable platelet-rich fibrin) in periodontal pockets as adjunctive therapy to scaling and root planing. 15 periodontal patients will receive a through traditional mechanical treatment (scaling and root planing). Each patient will receive subgingival i-PRF injected in half mouth and the opposite side will be injected with saline, immediately after the deep scaling session.
Detailed Description
The aim of the study is to evaluate the efficacy of i-PRF subgingival injection right after scaling and root planing as adjunctive therapy to traditional mechanical therapy. 15 periodontal patients will receive traditional mechanical supra and subgingival scaling and root planing. I-PRF will be applied subgingivally in the deep pockets in a half mouth design. The injected half mouth (study group) for each patient will be allocated randomly. The opposite side will be injected with saline (control group). Clinical parameters will be evaluated: plaque index (PI), bleeding on probing (BOP), probing depth (PD), clinical attachment level (CAL). Clinical measurements will be performed at baseline and at 8 weeks.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Periodontal Pockets
Keywords
periodontal pockets, injectable platelet-rich fibrin, saline
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
i-PRF (Test)
Arm Type
Experimental
Arm Description
injected subgingivally i-PRF after scaling and root planing
Arm Title
saline (Control)
Arm Type
Active Comparator
Arm Description
injected subgingivally saline after scaling and root planing
Intervention Type
Procedure
Intervention Name(s)
: i-PRF
Intervention Description
The description of this intervention has been already given before
Intervention Type
Procedure
Intervention Name(s)
saline
Intervention Description
The description of this intervention has been already given before
Primary Outcome Measure Information:
Title
Clinical attachment level (CAL)
Description
measure as the change in distance from the cementoenamel junction to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina")
Time Frame
baseline, 2 months
Title
Probing pocket depth (PD)
Description
measure as the change in distance from the gingival margin GM to the bottom of the gingival sulcus by using a periodontal probe (UNC 15 "University of North Carolina")
Time Frame
baseline, 2 months
Secondary Outcome Measure Information:
Title
full mouth Plaque Index Quigely Hein Index (modified by Turesky et al, 1970)
Description
0 No plaque
Separate flecks of plaque at the cervical margin of the tooth
A thin continuos band of plaque (up to one mm) at the cervical margin of the tooth
A band of plaque wider than one mm but covering less than one-third of the crown of the tooth
Plaque covering at least one-third but less than two-thirds of the crown of the tooth
Plaque covering two-thirds or more of the crown of the tooth labial/ buccal and lingual surfaces are assessed after using disclosing solution.
An index for the entire mouth is determined by dividing the total score by the number surfaces examined.
Time Frame
baseline, 2 months
Title
Modified Gingival Index (Trombelli et al. 2004)
Description
0 = Normal gingiva;
= Mild inflammation - slight change in color and slight edema;
= Moderate inflammation - redness, edema and glazing;
= Severe inflammation - marked redness and edema, ulceration with tendency to spontaneous bleeding.
will be evaluated visually
Time Frame
baseline, 2 months
Title
Bleeding on probing (BOP)
Description
All six sites of all teeth are assessed with regard to whether probing elicits bleeding (+) or not (-). The severity of gingivitis is expressed as a percentage.
- no bleeding upon probing (not recorded)
+ bleeding upon probing
Calculation:
BOP= Number of bleeding sites x100/ Number of sites evaluated will be evaluated visually and used a UNC-15 mm "University of North Carolina" periodontal probe
Time Frame
baseline, 2 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients are in general good health.
Patients are from both gender and are adult.
A sign informed consent from participation and permission to use obtained data for research purposes.
They have not taken medication known to interfere with periodontal tissue health or healing in the preceding 6 months.
Presence of bilateral periodontal pockets (≥5 mm) on the minimum of 2 teeth in each side.
Exclusion Criteria:
Patients less than 18 years' old
Immunosuppressive systemic diseases (like cancer, AIDS, diabetes…)
clotting and Hematological disorders
Medications influence on the gingival and periodontal tissues (like calcium channel blockers, or Long-term steroid use
The teeth with poor bad filling and poorly fitted restorations
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hala Albonni, DDS MSc
Organizational Affiliation
Syrian Private University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Hazem Sawaf, DDS MSc PhD
Organizational Affiliation
Syrian Private University
Official's Role
Study Chair
Facility Information:
Facility Name
Syrian Private University
City
Damascus
Country
Syrian Arab Republic
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
28154995
Citation
Miron RJ, Fujioka-Kobayashi M, Hernandez M, Kandalam U, Zhang Y, Ghanaati S, Choukroun J. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry? Clin Oral Investig. 2017 Nov;21(8):2619-2627. doi: 10.1007/s00784-017-2063-9. Epub 2017 Feb 2.
Results Reference
background
PubMed Identifier
30003342
Citation
Varela HA, Souza JCM, Nascimento RM, Araujo RF Jr, Vasconcelos RC, Cavalcante RS, Guedes PM, Araujo AA. Injectable platelet rich fibrin: cell content, morphological, and protein characterization. Clin Oral Investig. 2019 Mar;23(3):1309-1318. doi: 10.1007/s00784-018-2555-2. Epub 2018 Jul 12.
Results Reference
background
PubMed Identifier
28351189
Citation
Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets. 2018 Jan;29(1):48-55. doi: 10.1080/09537104.2017.1293807. Epub 2017 Mar 29.
Results Reference
background
PubMed Identifier
28165420
Citation
Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Behavior of Gingival Fibroblasts on Titanium Implant Surfaces in Combination with either Injectable-PRF or PRP. Int J Mol Sci. 2017 Feb 4;18(2):331. doi: 10.3390/ijms18020331.
Results Reference
background
PubMed Identifier
30294166
Citation
Kour P, Pudakalkatti PS, Vas AM, Das S, Padmanabhan S. Comparative Evaluation of Antimicrobial Efficacy of Platelet-rich Plasma, Platelet-rich Fibrin, and Injectable Platelet-rich Fibrin on the Standard Strains of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans. Contemp Clin Dent. 2018 Sep;9(Suppl 2):S325-S330. doi: 10.4103/ccd.ccd_367_18.
Results Reference
background
Learn more about this trial
Evaluation of Adjunctive Injectable PRF Therapy Used in Conjunction With Scaling and Root Planning
We'll reach out to this number within 24 hrs